Fluoroquinolones: Difference between revisions

(Text replacement - "Category:Drugs" to "Category:Pharmacology")
(Text replacement - "==Source==" to "==References== <references/>")
Line 19: Line 19:
*[[Antibiotics (Main)]]
*[[Antibiotics (Main)]]


==Source==
==References==
<references/>
*Goodman & Gilman's Pharmacology
*Goodman & Gilman's Pharmacology
*[http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126085.htm FDA info for Health Professionals]
*[http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm126085.htm FDA info for Health Professionals]

Revision as of 15:33, 27 June 2016

Indications

Adverse Effects

  • Black box warning from US FDA
  1. Tendon Rupture & Tendinitis [1]
  2. Peripheral Neuropathy[2]



See Also

References

  1. Gültuna S. et al. Ciprofloxacin induced tendinitis. J Clin Rheumatol. 2009;15 (4): 201-2
  2. Food and Drug Administration: Drug safety announcement about fluoroquinolones and possible peripheral neuropathy PDF